OrphanDrug
OrphanDrug
Pharma Knowledge Base

progressive bifocal chorioretinal atrophy

MeSH: C535356ORPHA: 75373

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

Progressive bifocal chorioretinal atrophy (PBCRA) is an early-onset chorioretinal dystrophy characterized by large atrophic macular and nasal retinal lesions, nystagmus, myopia, poor vision, and slow disease progression

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with progressive bifocal chorioretinal atrophy, sourced from HPO and Orphanet clinical annotations.

Visual impairmentMyopiaEsotropiaPigmentary retinopathyNystagmusChorioretinal dystrophyMacular atrophy

Classification & Codes

MeSH Code

C535356

Orphanet Code

ORPHA:75373
progressive bifocal chorioretinal atrophy
MeSHC535356
OrphanetORPHA:75373
Treatments0 drug(s)
Symptoms on record7 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO